Beverley Hunt


Beverley Jane Hunt is Professor of Thrombosis & Haemostasis at King’s College London, Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust, and Clinical Lead in Haematological Sciences at Viapath LLP. 

She has a large clinical practice, specialising in thrombosis and haemostasis & obstetric haematology. She leads on the management of VTE within GSTT. She set up the award-winning “Thrombosis” app – thrombosis management in elegant algorithms. Her laboratory work includes sitting on the board of Viapath LLP and leading in all aspects of haematological laboratory work.

She runs a research group with over 310 peer-reviewed publications to her name, and won the BMJ Research paper of the year 2011 with the CRASH-2 team. She is a recognised national and international expert in thrombosis & bleeding disorders. She sits on the editorial boards of the British Journal for Haematology, Journal of Thrombosis & Haemostasis, Lupus, & Seminars in Thrombosis & Haemostasis. She is a chair in the ISTH (International Society for Thrombosis & Haemostasis) Perioperative Haemostasis group. She lectures at 40+ national and international meetings annually. She works frequently with NICE; is on their Expert Panel, and is involved in rewriting the NICE thromboprophylaxis guidelines currently. She set up the BHS Obstetric Haematology Group with Dr Sue Pavord 12 years ago and this has flourished with twice yearly well attended meeting. She is chair of the British Society for Haematology External Affairs committee.

She is honorary president of “VTE Ireland” – the Irish platform to increase understanding of VTE & campaign for mandating venous thromboembolism (VTE) risk assessment in Irish hospitals. In recognition of her work in obstetric haematology she is the first ambassador for the antipodean organisation HOW (Haematologists in Obstetric & Woman’s’ health). She led on behalf of the UK thrombosis and haemostasis community in a successful bid to bring the ISTH meeting (10-12,000 delegates) to the Excel Centre, London in 2022.

In 2002, she founded and is now Medical Director of the thrombosis charity, ‘Lifeblood: the thrombosis charity’, which rebranded as Thrombosis UK. It aims to increase awareness of thrombosis especially VTE, to campaign for better care and lastly to fund research in VTE.  She is very proud that it is now a medium-sized charity with funding mainly fromand was Health Charity of the Year 2010 for its campaigning in the mandating of VTE risk assessment in UK hospitals to reduce the rate of hospital-acquired thrombosis: this has led to a 9% reduction on death due to VTE in England. She is a founding member of a team, sponsored by the ISTH, organising “World Thrombosis Day”. This aims to increase the global awareness of thrombosis especially VTE She leads on World Thrombosis Day campaigning to persuade the World Health Organisation to take VTE risk assessment to all hospital globally.